A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis
Clinical trial NCT03045523 · COMPLETED
Trial details
- NCT number
- NCT03045523
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2017-08-11
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.